June 14, 2013
AbbVie G.K. and Meiji Seika Pharma announced on June 12 that the two companies have initiated in Japan a PIII clinical trial of the antidepressant fluvoxamine maleate (brand names: Luvox from AbbVie and Depromel from Meiji Seika Pharma) in children...read more